Sign inJoin waitlistJoin the waitlist

KC

Kenji Cunnion

Professor of Clinical Practice · Old Dominion University

Credentials: · · ·

History

Pediatric Infectious Diseases
Duke University Hospital
1997–2000
Pediatrics
Virginia Commonwealth University Health System
1993–1994
Duke University School of Medicine
1989–1993

Research

Risk factors for nosocomial pneumonia: comparing adult critical-care populations
American Journal of Respiratory and Critical Care Medicine · 1996 · First of 6 authors · 126 citations
Capsule production and growth phase influence binding of complement to Staphylococcus aureus
Infection and Immunity · 2001 · First of 3 authors · Corresponding · 99 citations
Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis
Infection and Immunity · 2010 · Last of 7 authors · 89 citations

Clifford Mauriello
8 papers · 5 as a fellow
PK
Parvathi Kumar
8 papers · 1 as a fellow
Tushar Shah
7 papers
AW
Alice Werner
6 papers
CE
Charlene Echague
5 papers
LS
Laura Sass
4 papers
Michael Frank
4 papers
CG
Corinne Goldberg
3 papers
WB
William Bass
3 papers
AH
Antoinette Hood
2 papers
EB
Edward Buescher
2 papers
JP
Jessica Price
2 papers

Grants

PIC1 Inhibition of Myeloperoxidase Activity and Inflammation
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $412.1K · Eastern Virginia Medical School
2018–2021
Peptide Inhibition of Complement-Mediated Hemolysis After Xenotransfusion.
National Institute of Allergy and Infectious Diseases · R43
Contact PI · $149.9K · Children's Specialty Group, Pllc
2016–2017
Staphylococcus Aureus Binds Factor H to Moderate Complement Host Defense
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $394.6K · Eastern Virginia Medical School
2009–2011
Complement and the Clearance of Staphylococcus Aureus
National Institute of Allergy and Infectious Diseases · K08
Contact PI · $532.9K · Eastern Virginia Medical School
2002–2007

Clinical trials

Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess
Principal investigator · Completed · Phase 1, Phase 2
Eastern Virginia Medical School
2016–2017
A Clinical Study to Determine the Safety, Tolerability and Effect of RLS-0071 Doses When Given to Healthy Adults After Inhaling LPS
Study chair · Completed · Phase 1
ReAlta Life Sciences, Inc.
2022
A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure
Study chair · Withdrawn · Phase 1
ReAlta Life Sciences, Inc.
2021–2022